DCM
MDGL icon

Driehaus Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Driehaus Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.9M Sell
78,094
-32,866
-30% -$16.8M 0.24% 134
2026
Q1 		$58.1M Sell
110,960
-706
-0.6% -$337K 0.43% 73
2025
Q4 		$65M Sell
111,666
-4,308
-4% -$2.2M 0.44% 73
2025
Q3 		$53.2M Buy
+115,974
New +$43.3M 0.38% 83
2024
Q2 		– Sell
-50,709
Closed -$13.5M – 421
2024
Q1 		$13.5M Buy
+50,709
New +$11.9M 0.13% 205

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Driehaus Capital Management's MDGL Position: Q2 2026 in Review

Driehaus Capital Management reduced its Madrigal Pharmaceuticals (MDGL) stake by 30% in Q2 2026, selling an estimated $16.8M and leaving 78,094 shares worth $41.9M. The position accounts for 0.24% of the portfolio, ranked #134.

Driehaus Capital Management first reported a position in MDGL in Q1 2024 and has held it in 5 quarters since. The position peaked at $65M in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Driehaus Capital Management held 78,094 shares of Madrigal Pharmaceuticals worth $41.9M as of Q2 2026.
  • Driehaus Capital Management sold 32,866 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $16.8M.
  • Madrigal Pharmaceuticals made up 0.24% of Driehaus Capital Management's portfolio in Q2 2026, its #134 holding.
  • Driehaus Capital Management first reported a position in Madrigal Pharmaceuticals in Q1 2024 and has held it in 5 quarters since.
  • Driehaus Capital Management's Madrigal Pharmaceuticals position peaked at $65M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.